MAT
56
4
GILD
65
2
ABBV
55
2
CTSH
55
3
AMG
52
6
BLK
60
2
AME
72
12
BDX
30
2
KEY
57
4
EXR
59
4
GRMN
55
2
GT
46
-4
HPQ
38
-10
IPG
33
-10
BMY
53
3
MU
59
3
BWA
55
5
MA
71
2
FIS
58
-7
LEG
47
3
MAT
56
4
GILD
65
2
ABBV
55
2
CTSH
55
3
AMG
52
6
BLK
60
2
AME
72
12
BDX
30
2
KEY
57
4
EXR
59
4
GRMN
55
2
GT
46
-4
HPQ
38
-10
IPG
33
-10
BMY
53
3
MU
59
3
BWA
55
5
MA
71
2
FIS
58
-7
LEG
47
3
Financhill
Back

iShares JPX-Nikkei 400 ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
72

JPXN
iShares JPX-Nikkei 400 ETF

Last Price:
$78.6400
Seasonality Move:
-0.04%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$17.40
Seasonality Move:
0.23%
Buy
72
iShares JPX-Nikkei 400 ETF (JPXN) is a Buy

Is iShares JPX-Nikkei 400 ETF a Buy, Sell or Hold?

  • The current iShares JPX-Nikkei 400 ETF [JPXN] share price is $78.7241. The Score for JPXN is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • JPXN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.41. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JPXN Stock Price Chart

What is iShares JPX-Nikkei 400 ETF's stock price today?

  • The iShares JPX-Nikkei 400 ETF share price today is $78.7241
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JPXN is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

JPXN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.09 Buy
Relative Strength Index (14 RSI): 61.46 Buy
Chaikin Money Flow: 8369 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.0558 - 78.0558) Buy
Bollinger Bands (100): (70.7162 - 76.3362) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 44.4 Sell
Chaikin Money Flow: 1588413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.89 - 18.97) Sell
Bollinger Bands (100): (18.81 - 29.13) Sell

JPXN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 78.06 Buy
20-day SMA: 77.33 Buy
50-day SMA: 74.73 Buy
200-day SMA: 73.73 Buy
8-day EMA: 78.16 Buy
20-day EMA: 77.17 Buy
50-day EMA: 75.52 Buy
200-day EMA: 73.5 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.49 Sell
20-day SMA: 17.89 Sell
50-day SMA: 19.51 Sell
200-day SMA: 28.26 Sell
8-day EMA: 17.33 Buy
20-day EMA: 17.78 Sell
50-day EMA: 19.75 Sell
200-day EMA: 28.32 Sell

iShares JPX-Nikkei 400 ETF Earnings Growth & JPXN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

iShares JPX-Nikkei 400 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):